Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Christina Ashburner"'
Autor:
Christina Ashburner, Arthur D’Harlingue, Rosanna Spicer, Suma P. Shankar, Shimul Chowdhury, Juliette Hunt, David Dimmock, Katarzyna A. Ellsworth, Neda Zadeh, Bryce Waldman, Lauge Farnaes, Wendy Benson, Madelena Martin, Jason Knight, Sara A. Caylor, Ofelia Vargas-Shiraishi, Aaina Kochhar, Mario Augusto Rojas, Charlotte A. Hobbs, Priscilla Joe, Katherine A. Rauen, Maries Joseph, Kathleen Houtchens, Richard Kronick, Ami Doshi, Adam Schwarz, Stephen F. Kingsmore, Carolina I. Galarreta, Jason Carmichael, Jolie Limon, Elaine Cham, Robert H. Kaplan, Jeanne Carroll, Kristen Wigby, John P. Cleary
Publikováno v:
American journal of human genetics, vol 108, iss 7
Am J Hum Genet
Am J Hum Genet
Genetic disorders are a leading contributor to mortality in neonatal and pediatric intensive care units (ICUs). Rapid whole-genome sequencing (rWGS)-based rapid precision medicine (RPM) is an intervention that has demonstrated improved clinical outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a195984a6ab40c8a7ab4e62f2b4ffada
https://doi.org/10.1016/j.ajhg.2021.05.008
https://doi.org/10.1016/j.ajhg.2021.05.008
Autor:
Andrea N. Edginton, Anjali Sharathkumar, Fernando F. Corrales-Medina, Christina Ashburner, Samuel Sarmiento, Pierre Chelle, Azusa Nagao, Stacy E. Croteau, Santiago Bonanad, Meera Chitlur, Juan Eduardo Megías-Vericat, Jennifer Lissick, Huyen Tran, Vinod Balasa, Cindy H. T. Yeung, Young Shil Park, Alfonso Iorio, Tung Wynn
Publikováno v:
CLINICAL PHARMACOKINETICS
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Rurioctacog alfa pegol (Adynovate) is a modified recombinant factor VIII concentrate used for treating hemophilia A. Aiming to improve treatment tailoring on the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) platform for p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2484523dc80d42f4b913e06ed3ae8a72
https://doi.org/10.1007/s40262-019-00809-6
https://doi.org/10.1007/s40262-019-00809-6
Autor:
Pierre, Chelle, Cindy H T, Yeung, Stacy E, Croteau, Jennifer, Lissick, Vinod, Balasa, Christina, Ashburner, Young Shil, Park, Santiago, Bonanad, Juan Eduardo, Megías-Vericat, Azusa, Nagao, Tung, Wynn, Fernando, Corrales-Medina, Huyen, Tran, Anjali, Sharathkumar, Meera, Chitlur, Samuel, Sarmiento, Andrea, Edginton, Alfonso, Iorio
Publikováno v:
Clinical pharmacokinetics. 59(2)
Rurioctacog alfa pegol (Adynovate) is a modified recombinant factor VIII concentrate used for treating hemophilia A. Aiming to improve treatment tailoring on the Web-Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) platform for p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b50a3a951684f01427673d294bcd1220
https://pubmed.ncbi.nlm.nih.gov/31435896
https://pubmed.ncbi.nlm.nih.gov/31435896